Molecular Cancer therapy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, suppresses the expression of proto-oncogene N-Myc via up regulation of its target gene, 11/March/2014, 21.10

Cell Proliferation: C/EBPzeta (CHOP/GADD153) increases the expression of MTA1 via down regulation of its target gene, 11/March/2014, 20.38
March 11, 2014
Molecular Cancer stem cell therapy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, suppresses the expression of reprogramming protein Nanog via up regulation of its target gene, 11/March/2014, 21.14
March 11, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular Cancer therapy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, suppresses the expression of proto-oncogene N-Myc via up regulation of its target gene, 11/March/2014, 21.10,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.